Yeah. So we have trials going on, both with multiple carriers in the United States, leading carriers in the United States. We are now starting trials also in Europe. So I think that Europe is definitely going to follow the United States, it will be probably second tier. Sometime in the first half of next year, we're hopeful that we'll be able to also launch it in Europe. But to your question about the size of the market, we believe that this market is very, very large scale, anywhere from tens of thousands of units a year to well over 100,000 units a year. That would not even be scratching the size for the potential of the market. That being because this is going to be the lowest cost mission critical push to talk device on the market. There is nothing that is going to be in this price level. The price level is around $300, just to give you color. So every 10,000 units is about $3 million, 100,000 units would be about $30 million. All of the carriers are very, very interested in what is called first responders, but not only first responders, also second tier first responders. And the second tier first responder could be waste management, it could be yellow school buses, drivers, it could be utilities, right? Those are all also considered first responders. And both AT&T FirstNet and Verizon and also TNT Mobile, they're very, very interested in getting into that market. The best way to do it is with a mission critical push to talk device. So because the device is very unique, because you don't have to, it's a perfect upgrade from the LMR in this case. If you saw on the webinar, anybody that's used a radio for the past 20 years, for them taking this new device, it's very, very easy upgrade, right. You don't have to really learn anything, you push the button, you choose the channel, and that's it. So in that sense, we think that it has very, very large scale potential. And even in the markets that we're selling right now, in Israel and in other markets in Europe, they are extremely interested in this product. We're going to be starting trials soon. And we think that it has a global appeal. So we think that that's going to be a very good product for us.